Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Publications
Found 27 results
Author
[
Title
]
Type
Year
Filters:
Author
is
Longman, Randy S
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
Hirten R
,
Longman RS
,
Bosworth BP
,
Steinlauf A
,
Scherl E
. 2015.
Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease.
.
Am J Gastroenterol. 110(12):1737-8.
T
Braun D
,
Longman RS
,
Albert ML
. 2005.
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation.
.
Blood. 106(7):2375-81.
Zegarra-Ruiz DF
,
Kim DV
,
Norwood K
,
Kim M
,
Wu W-JH
,
Saldana-Morales FB
,
Hill AA
,
Majumdar S
,
Orozco S
,
Bell R
et al.
. 2021.
Thymic development of gut-microbiota-specific T cells.
.
Nature. 594(7863):413-417.
S
Jacob V
,
Crawford C
,
Cohen-Mekelburg S
,
Viladomiu M
,
Putzel GG
,
Schneider Y
,
Chabouni F
,
OʼNeil S
,
Bosworth B
,
Woo V
et al.
. 2017.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
.
Inflamm Bowel Dis. 23(6):903-911.
R
J Blander M
,
Longman RS
,
Iliev ID
,
Sonnenberg GF
,
Artis D
. 2017.
Regulation of inflammation by microbiota interactions with the host.
.
Nat Immunol. 18(8):851-860.
Longman RS
,
Moreira RK
,
Littman DR
,
Green PHR
,
Sethi A
. 2012.
A rare intestinal infection with systemic effects.
.
Gastroenterol Hepatol (N Y). 8(1):60-3.
P
Longman RS
,
Talal AH
,
Jacobson IM
,
Albert ML
,
Rice CM
. 2004.
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.
.
Blood. 103(3):1026-9.
N
Longman RS
,
Talal AH
,
Jacobson IM
,
Rice CM
,
Albert ML
. 2005.
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.
.
J Infect Dis. 192(3):497-503.
Lukin DJ
,
Funez-dePagnier G
,
Lima S
,
Lai D
,
Duenas-Bianchi L
,
Ahmed W
,
Jacob V
,
Battat R
,
Scherl E
,
Longman RS
. 2021.
No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
.
Clin Gastroenterol Hepatol. 19(11):2312-2314.e3.
M
Castellanos JG
,
Woo V
,
Viladomiu M
,
Putzel G
,
Lima S
,
Diehl GE
,
Marderstein AR
,
Gandara J
,
Perez AR
,
Withers DR
et al.
. 2018.
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
.
Immunity. 49(6):1077-1089.e5.
Diehl GE
,
Longman RS
,
Zhang J-X
,
Breart B
,
Galan C
,
Cuesta A
,
Schwab SR
,
Littman DR
. 2013.
Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells.
.
Nature. 494(7435):116-20.
L
Barba-Spaeth G
,
Longman RS
,
Albert ML
,
Rice CM
. 2005.
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
.
J Exp Med. 202(9):1179-84.
I
Castellanos JG
,
Longman RS
. 2020.
Innate lymphoid cells link gut microbes with mucosal T cell immunity.
.
Gut Microbes. 11(2):231-236.
Viladomiu M
,
Kivolowitz C
,
Abdulhamid A
,
Dogan B
,
Victorio D
,
Castellanos JG
,
Woo V
,
Teng F
,
Tran NL
,
Sczesnak A
et al.
. 2017.
IgA-coated enriched in Crohn's disease spondyloarthritis promote T17-dependent inflammation.
.
Sci Transl Med. 9(376)
F
Longman RS
,
Littman DR
. 2015.
The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity.
.
Curr Opin Rheumatol. 27(4):381-7.
E
Scher JU
,
Sczesnak A
,
Longman RS
,
Segata N
,
Ubeda C
,
Bielski C
,
Rostron T
,
Cerundolo V
,
Pamer EG
,
Abramson SB
et al.
. 2013.
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.
.
Elife (Cambridge). 2:e01202.
Gogokhia L
,
Buhrke K
,
Bell R
,
Hoffman B
,
D Brown G
,
Hanke-Gogokhia C
,
Ajami NJ
,
Wong MC
,
Ghazaryan A
,
Valentine JF
et al.
. 2019.
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
.
Cell Host Microbe. 25(2):285-299.e8.
Longman RS
,
Remotti H
,
Green PH
. 2011.
Esophagitis dissecans superficialis.
.
Gastrointest Endosc. 74(2):403-4.
Lima SF
,
Longman RS
. 2021.
Eating for Two: Diet and the Microbiome in Ulcerative Colitis.
.
J Crohns Colitis.
D
Lima S
,
Longman RS
. 2021.
A Diamond in the Rough: IgA-Seq Signatures Stratify New Onset IBD.
.
Cell Host Microbe. 29(1):10-12.
Longman RS
,
Braun D
,
Pellegrini S
,
Rice CM
,
Darnell RB
,
Albert ML
. 2007.
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation.
.
Blood. 109(3):1113-22.
Kumar A
,
Lukin D
,
Battat R
,
Schwartzman M
,
Mandl LA
,
Scherl E
,
Longman RS
. 2020.
Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.
.
J Gastroenterol. 55(7):667-678.
Viladomiu M
,
Longman RS
. 2021.
Decoding the matrix: multiomics reveals host-microbe biomarker for inflammatory bowel disease.
.
J Clin Invest. 131(9)
C
Longman RS
,
Diehl GE
,
Victorio DA
,
Huh JR
,
Galan C
,
Miraldi ER
,
Swaminath A
,
Bonneau R
,
Scherl EJ
,
Littman DR
. 2014.
CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.
.
J Exp Med. 211(8):1571-83.
B
Lukin DJ
,
Kumar A
,
Hajifathalian K
,
Sharaiha RZ
,
Scherl EJ
,
Longman RS
. 2020.
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
.
Gastroenterology. 159(4):1541-1544.e2.
1
(current)
2
next ›
last »